arrow
R

Ralf-Dieter Hofheinz

Universität Heidelberg
H指数:57
被引数:1.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Chemotherapy for patients with circulating tumour DNA positive, stage II colon cancer (CIRCULATE) – an AIO / ABCSG trial

循环肿瘤DNA阳性、II期结肠癌患者的化疗(CIRCULATE)——一项AIO/ABCSG试验

2026-05-310
OAAI
Aflibercept and 5-FU vs. FOLFOX as 1st line treatment for older adults or frail elderly patients with metastatic colorectal cancer – the randomized phase 2 AIO / IKF ELDERLY trial (AIO-KRK-0117 / IKF 629)

阿柏西普和5-FU对比FOLFOX作为老年或虚弱老年患者转移性结直肠癌的一线治疗方案——随机II期AIO / IKF ELDERLY试验(AIO-KRK-0117 / IKF 629)。

2026-03-240
PRE
Treatment landscape from first- to third-line therapy and quality of life data of patients with pancreatic cancer from the prospective German PARAGON (Platform for Outcome, Quality of Life, and Translational Research on Pancreatic Cancer) registry (IKF-PARAGON study)

从一线到三线治疗的胰腺癌患者治疗格局及生活质量数据,来自德国PARAGON(胰腺癌结局、生活质量及转化研究平台)登记研究(IKF-PARAGON研究)。

2025-12-010
OAAI
Expert-guided approaches to complementary interventions for common side effects of cancer therapies: a practice-based perspective from integrative oncology centers in Baden-Württemberg; Germany

专家指导的癌症治疗常见副作用补充干预方法:来自德国巴登-符腾堡州整合肿瘤中心的实践视角

2025-11-060
OAAI
Perioperative pembrolizumab, trastuzumab and FLOT in HER2-positive localized esophagogastric adenocarcinoma: a phase 2 trial

围手术期帕博利珠单抗、曲妥珠单抗及FLOT方案在HER2阳性局限性食管胃腺癌中的疗效:一项Ⅱ期临床试验

2025-10-180
OAAI
Structured Magnetic Resonance Imaging Assessment Improves Diagnosis of Pathological Complete Response in Rectal Cancer after Neoadjuvant Chemoradiation

结构化磁共振成像评估可提高直肠癌新辅助放化疗后病理完全缓解的诊断。

2025-09-010
PRE
Individually compounded multi-chamber vs. standardized parenteral nutrition bags in solid tumors–A randomized clinical trial (IKF-010)

个体化配制的多腔袋与标准化肠外营养袋在实体瘤中的应用比较——一项随机临床试验(IKF-010)

2025-06-240
OA
Quality of Life After Two Sequences of Total Neoadjuvant Treatment in Patients With Locally Advanced Rectal Cancer in the Randomized CAO/ARO/AIO-12 Phase 2 Trial

CAO/ARO/AIO-12随机对照试验第2阶段中,局部晚期直肠癌患者接受两种序贯总新辅助治疗后生活质量研究

2025-05-210
OAAI
Prognosis and quality of life in patients with locally advanced rectal cancer after abdominoperineal resection in the CAO/ARO/AIO-04 randomized phase 3 trial
2025-02-130
OAAI
Chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: Pooled analysis of the CAO/ARO/AIO-12 and the OPRA randomized phase 2 trials

放化疗加诱导或巩固化疗作为局部晚期直肠癌的总新辅助治疗: CAO/ARO/AIO-12和OPRA随机2期试验的汇总分析

2024-10-010
PRE
Functional status and quality of life in older patients with advanced esophageal squamous cell cancer receiving second-line nivolumab ± ipilimumab therapy: A post hoc analysis of the phase 2, multicenter RAMONA study
2024-09-010
PRE
Modified FOLFOX plus/minus nivolumab and ipilimumab vs FLOT plus nivolumab in patients with previously untreated advanced or metastatic adenocarcinoma of the stomach or gastroesophageal junction: Final results of the IKF-AIO-Moonlight trial

改良FOLFOX联合或不联合纳武利尤单抗和伊匹木单抗对比FLOT联合纳武利尤单抗治疗既往未接受治疗的胃或胃食管结合部腺癌晚期或转移性患者的最终结果:IKF-AIO-Moonlight试验

2024-09-012
PRE